We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
Invesco International Dividend Achievers ETF
PID
$919M
| $172K | ﹤0.01% |
9,830
| – | – |
|
1627
Semtech
SMTC
$13B
| $172K | ﹤0.01% |
2,218
-2,593
| -54% | -$178K |
|
1628
Northrim BanCorp
NRIM
$587M
| $171K | ﹤0.01% |
16,132
+132
| +0.8% | +$1.36K |
|
1629
Invesco WilderHill Clean Energy ETF
PBW
$461M
| $171K | ﹤0.01% |
2,219
+574
| +35% | +$46.9K |
|
1630
Telephone and Data Systems
TDS
$3.75B
| $171K | ﹤0.01% |
8,777
+143
| +2% | +$2.97K |
|
1631
C3.ai
AI
$1.59B
| $170K | ﹤0.01% |
3,672
+585
| +19% | +$29.8K |
|
1632
DaVita
DVA
$11.7B
| $170K | ﹤0.01% |
1,470
+854
| +139% | +$107K |
|
1633
MaxLinear
MXL
$6.8B
| $170K | ﹤0.01% |
3,460
+104
| +3% | +$5.03K |
|
1634
W.W. Grainger
GWW
$60.2B
| $169K | ﹤0.01% |
431
+12
| +3% | +$5.21K |
|
|
AIO
1635
Virtus Artificial Intelligence & Technology Opportunities Fund
AIO
$903M
| $167K | ﹤0.01% |
6,294
+4,294
| +215% | +$117K |
|
1636
iShares Global Healthcare ETF
IXJ
$4.19B
| $167K | ﹤0.01% |
2,008
+1,216
| +154% | +$105K |
|
1637
Lamb Weston
LW
$7.19B
| $167K | ﹤0.01% |
2,726
+556
| +26% | +$37.6K |
|
1638
Invesco S&P 500 Top 50 ETF
XLG
$11B
| $167K | ﹤0.01% |
5,080
+10
| +0.2% | +$339 |
|
1639
PIMCO Corporate & Income Opportunity Fund
PTY
$2.51B
| $166K | ﹤0.01% |
9,103
-162
| -2% | -$3.23K |
|
|
SWN
1640
DELISTED
Southwestern Energy Company
SWN
| $166K | ﹤0.01% |
30,000
-248
| -0.8% | -$1.21K |
|
1641
BlackRock Health Sciences Trust
BME
$570M
| $165K | ﹤0.01% |
3,466
-96
| -3% | -$4.68K |
|
1642
John Wiley & Sons Class A
WLY
$2.66B
| $165K | ﹤0.01% |
3,196
+11
| +0.3% | +$631 |
|
1643
Arvinas
ARVN
$572M
| $164K | ﹤0.01% |
2,000
-11
| -0.5% | -$972 |
|
1644
PLDT
PHI
$4.33B
| $164K | ﹤0.01% |
5,055
-29
| -0.6% | -$786 |
|
|
FSD
1645
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
| $164K | ﹤0.01% |
10,349
+1,162
| +13% | +$18.5K |
|
|
DVAX
1646
DELISTED
Dynavax Technologies
DVAX
| $163K | ﹤0.01% |
+8,500
| New | +$113K |
|
1647
WisdomTree International Quality Dividend Growth Fund
IQDG
$734M
| $163K | ﹤0.01% |
4,282
+31
| +0.7% | +$1.26K |
|
1648
Kontoor Brands
KTB
$4.26B
| $163K | ﹤0.01% |
3,263
+36
| +1% | +$2K |
|
1649
Alliant Energy
LNT
$18B
| $163K | ﹤0.01% |
2,914
-23,015
| -89% | -$1.36M |
|
1650
Avantor
AVTR
$9.19B
| $162K | ﹤0.01% |
3,984
-247
| -6% | -$9.65K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.